Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis.
Nygaard
T G
TG
Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York 10032.
D000293:Adolescent; D000328:Adult; D002648:Child; D003937:Diagnosis, Differential; D004421:Dystonia / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D010302:Parkinson Disease, Secondary / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D010641:Phenotype
D007980:Levodopa